GMT Science

GMT Science is an innovative medtech company harnessing standardized, high-resolution stool metagenomics and AI-driven data science to develop in vitro diagnostics (IVD), brought to clinicians via medical laboratories. It brings together a multidisciplinary team of microbiome experts, clinicians, AI specialists, data scientists and medical software engineers to develop in vitro diagnostics leveraging the gut microbiome. GMT Science has developed BiomScope®, a proprietary CE-marked IVD software to accurately measure microbial species, genes and functions, outperforming reference metagenomics pipelines. Its first product, IOScope®, is an in vitro diagnostics predicting the response to immune checkpoint inhibitors (ICI). By predicting the response to ICI, IOScope® allows personalizing treatments, maximizes their benefits and optimizes medical spendings. The company leverages its collaborations with leading hospitals across Europe and North America and its unique database of over 20,000 curated clinical samples to discover and validate indicationspecific microbiome biomarkers.